cosing 0.3.1 → 0.3.2
Sign up to get free protection for your applications and to get access to all the features.
- checksums.yaml +4 -4
- data/data/annex.II.csv +714 -714
- data/data/annex.III.csv +1178 -1178
- data/data/annex.IV.csv +14 -14
- data/data/annex.V.csv +66 -66
- data/data/annex.VI.csv +72 -72
- data/data/ingredients.csv +18 -39
- data/lib/cosing/version.rb +1 -1
- metadata +3 -3
data/data/annex.IV.csv
CHANGED
@@ -49,7 +49,7 @@ reference_number,inn,colour_index_number,cas_number,ec_number,colour,product_typ
|
|
49
49
|
48,"2,2'-[(3,3'-Dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(4-chloro-2,5-dimethoxyphenyl)-3-oxobutyramide]","CI 21108",5567-15-7,226-939-8,Yellow,,"Rinse-off products",,"Maximum 3,3'-dimethylbenzidine concentration in the colouring agent: 5 ppm","(EC) 2009/1223",,,"2,2'-[(3,3'-Dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(4-chloro-2,5-dimethoxyphenyl)-3-oxobutyramide]","CI 21108",,14/08/2020
|
50
50
|
49,"2,2'-[Cyclohexylidenebis[(2-methyl-4,1-phenylene)azo]]bis[4-cyclohexylphenol]","CI 21230 /SOLVENT YELLOW 29",6706-82-7,229-754-0,Yellow,,"Not to be used in products applied on mucous membranes",,,"(EC) 2009/1223",,,"2,2'-[Cyclohexylidenebis[(2-methyl-4,1-phenylene)azo]]bis[4-cyclohexylphenol]","CI 21230,SOLVENT YELLOW 29,",,14/08/2020
|
51
51
|
50,"Disodium 4,6-dihydroxy-3-[[4-[1-[4-[[1-hydroxy-7-[(phenylsulphonyl)oxy]-3-sulphonato-2-naphthyl]azo]phenyl]cyclohexyl]phenyl]azo]naphthalene-2-sulphonate","CI 24790",13421-53-9,236-531-1,Red,,"Rinse-off products",,,"(EC) 2009/1223",,,"Disodium 4,6-dihydroxy-3-[[4-[1-[4-[[1-hydroxy-7-[(phenylsulphonyl)oxy]-3-sulphonato-2-naphthyl]azo]phenyl]cyclohexyl]phenyl]azo]naphthalene-2-sulphonate","CI 24790",,14/08/2020
|
52
|
-
51,1-(4-(Phenylazo)phenylazo)-2-naphthol,"CI 26100 /SOLVENT RED 23",85-86-9,201-638-4,Red,,"Not to be used in products applied on mucous membranes",,"Purity criteria:
|
52
|
+
51,1-(4-(Phenylazo)phenylazo)-2-naphthol,"CI 26100 /SOLVENT RED 23",85-86-9,201-638-4,Red,,"Not to be used in products applied on mucous membranes",,"Purity criteria:
|
53
53
|
anilin","(EC) 2009/1223",,"Opinion on CI 26100 (Solvent Red 23 not defended as hair dye)",1-(4-(Phenylazo)phenylazo)-2-naphthol,"CI 26100,SOLVENT RED 23",,14/08/2020
|
54
54
|
52,"Tetrasodium 6-amino-4-hydroxy-3-[[7-sulphonato-4-[(4-sulphonatophenyl)azo]-1-naphthyl]azo]naphthalene-2,7-disulphonate","CI 27755",2118-39-0,218-326-9,Black,,,,,"(EC) 2009/1223",,,"Tetrasodium 6-amino-4-hydroxy-3-[[7-sulphonato-4-[(4-sulphonatophenyl)azo]-1-naphthyl]azo]naphthalene-2,7-disulphonate","CI 27755,",,14/08/2020
|
55
55
|
53,"Tetrasodium 1-acetamido-2-hydroxy-3-(4-((4-sulphonatophenylazo)-7-sulphonato-1-naphthylazo))naphthalene-4,6-disulphonate","CI 28440",2519-30-4,219-746-5,Black,,,,"Purity criteria as set out in Commission Directive 95/45/EC (E 151)","(EC) 2009/1223",,,"Tetrasodium 1-acetamido-2-hydroxy-3-(4-((4-sulphonatophenylazo)-7-sulphonato-1-naphthylazo))naphthalene-4,6-disulphonate","CI 28440",,14/08/2020
|
@@ -79,7 +79,7 @@ anilin","(EC) 2009/1223",,"Opinion on CI 26100 (Solvent Red 23 not defended as h
|
|
79
79
|
77,"3',6'-Dihydroxy-4',5'-dinitrospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one","CI 45396",24545-86-6,246-308-0,Orange,,,"1%, when used in lip products","Only in free acid form, when used in lip products","(EC) 2009/1223",,,"3',6'-Dihydroxy-4',5'-dinitrospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one","CI 45396",,14/08/2020
|
80
80
|
78,"Dipotassium 3,6-dichloro-2-(2,4,5,7-tetrabromo-6-oxido-3-oxoxanthen-9-yl)benzoate","CI 45405",6441-77-6,229-225-4,Red,,"Not to be used in eye products",,"Not more than 1% 2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid and 2% 2-(bromo-6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid","(EC) 2009/1223",,,"Dipotassium 3,6-dichloro-2-(2,4,5,7-tetrabromo-6-oxido-3-oxoxanthen-9-yl)benzoate","CI 45405",,14/08/2020
|
81
81
|
79,"3,4,5,6-Tetrachloro-2-(1,4,5,8-tetrabromo-6-hydroxy-3-oxoxanthen-9-yl)benzoic acid and its insoluble barium, strontium and zirconium lakes, salts and pigments","CI 45410",18472-87-2,242-355-6,Red,,,,"Not more than 1% 2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid and 2% 2-(bromo-6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid","(EC) 2009/1223",,,"3,4,5,6-Tetrachloro-2-(1,4,5,8-tetrabromo-6-hydroxy-3-oxoxanthen-9-yl)benzoic acid and its soluble barium, strontium and zirconium lakes, salts and pigments","ACID RED 92,CI 45410,ACID RED 92",,22/06/2023
|
82
|
-
80,"Disodium 2-(2,4,5,7-tetraiodo-6-oxido-3-oxoxanthen-9-yl)benzoate and its insoluble barium, strontium and zirconium lakes, salts and pigments","CI 45430",12227-78-0,240-474-8,Red,,,,"Purity criteria as set out in Commission Directive 95/45/EC (E 127)
|
82
|
+
80,"Disodium 2-(2,4,5,7-tetraiodo-6-oxido-3-oxoxanthen-9-yl)benzoate and its insoluble barium, strontium and zirconium lakes, salts and pigments","CI 45430",12227-78-0,240-474-8,Red,,,,"Purity criteria as set out in Commission Directive 95/45/EC (E 127)
|
83
83
|
","(EC) 2009/1223",,"Opinion on Erythrosine (CI 45430)","Disodium 2-(2,4,5,7-tetraiodo-6-oxido-3-oxoxanthen-9-yl)benzoate and its insoluble barium, strontium and zirconium lakes, salts and pigments","ACID RED 51,CI 45430,PIGMENT RED 172 ALUMINUM LAKE,",,14/08/2020
|
84
84
|
81,"1,3-Isobenzofurandione, reaction products with methylquinoline and quinoline","CI 47000 / SOLVENT YELLOW 33",8003-22-3,232-318-2,Yellow,,"Not to be used in products applied on mucous membranes",,,"(EC) 2009/1223",,,"1,3-Isobenzofurandione, reaction products with methylquinoline and quinoline","CI 47000,SOLVENT YELLOW 33,",,14/08/2020
|
85
85
|
82,"1H-Indene-1,3(2H)-dione, 2-(2-quinolinyl)-, sulfonated, sodium salts","CI 47005","38615-46-2 ; 8004-92-0; 95193-83-2","-; -; 305-897-5",Yellow,,,,"Purity criteria as set out in Commission Directive 95/45/EC (E 104)","(EC) 2009/1223",,,"1H-Indene-1,3(2H)-dione, 2-(2-quinolinyl)-, sulfonated, sodium salts","CI 47005,,",,14/08/2020
|
@@ -126,15 +126,15 @@ anilin","(EC) 2009/1223",,"Opinion on CI 26100 (Solvent Red 23 not defended as h
|
|
126
126
|
123,"Bismuth chloride oxide","CI 77163",7787-59-9,232-122-7,White,,,,,"(EC) 2009/1223",,,"Bismuth chloride oxide","CI 77163",,14/08/2020
|
127
127
|
124,"Calcium carbonate","CI 77220",471-34-1,"207-439-9 / 215-279-6",White,,,,"Purity criteria as set out in Commission Directive 95/45/EC (E 170)","(EC) 2009/1223",,,"Calcium carbonate","CALCIUM CARBONATE,CI 77220",,14/08/2020
|
128
128
|
125,"Calcium sulfate","CI 77231","7778-18-9 / 10034-76-1 / 10101-41-4","231-900-3 / - / -",White,,,,,"(EC) 2009/1223",,,"Calcium sulfate","CALCIUM SULFATE,CI 77231,,",,14/08/2020
|
129
|
-
126a,"carbon black (nano)","CI 77266",1333-86-4,215-609-9,Black,,,10%,"Not to be used in applications that may lead to exposure of the end user's lungs by inhalation.
|
130
|
-
O
|
131
|
-
nly nanomaterials having the following characteristics are allowed:
|
132
|
-
— Purity > 97 %, with the following impurity profile: Ash content ≤ 0,15 %, total sulphur ≤ 0,65 %, total PAH ≤ 500 ppb and benzo(a)pyrene ≤ 5 ppb, dibenz(a,h)anthracene ≤ 5 ppb, total As ≤ 3 ppm, total Pb ≤ 10 ppm, and total Hg ≤ 1 ppm;
|
133
|
-
— Primary particle size ≥ 20 nm.’","(EC) 2016/1120",,"Opinionon Carbon Black (nano-form),Opinion for clarification of the meaning of the term ""sprayable
|
129
|
+
126a,"carbon black (nano)","CI 77266",1333-86-4,215-609-9,Black,,,10%,"Not to be used in applications that may lead to exposure of the end user's lungs by inhalation.
|
130
|
+
O
|
131
|
+
nly nanomaterials having the following characteristics are allowed:
|
132
|
+
— Purity > 97 %, with the following impurity profile: Ash content ≤ 0,15 %, total sulphur ≤ 0,65 %, total PAH ≤ 500 ppb and benzo(a)pyrene ≤ 5 ppb, dibenz(a,h)anthracene ≤ 5 ppb, total As ≤ 3 ppm, total Pb ≤ 10 ppm, and total Hg ≤ 1 ppm;
|
133
|
+
— Primary particle size ≥ 20 nm.’","(EC) 2016/1120",,"Opinionon Carbon Black (nano-form),Opinion for clarification of the meaning of the term ""sprayable
|
134
134
|
applications/products"" for the nano forms of Carbon Black CI 77266, Titanium Oxide and Zinc Oxide","carbon black (nano) ","CI 77266",,14/08/2020
|
135
|
-
126,"Carbon black","CI 77266",1333-86-4,215-609-9,Black,,,,"Purity > 97 %, with the following impurity profile:
|
136
|
-
Ash content ≤ 0,15 %, total sulphur ≤ 0,65 %, total PAH ≤ 500 ppb and benzo(a)pyrene ≤ 5 ppb, dibenz(a,h)anthracene ≤ 5 ppb, total As ≤ 3 ppm, total Pb ≤ 10 ppm, total Hg ≤ 1 ppm.
|
137
|
-
|
135
|
+
126,"Carbon black","CI 77266",1333-86-4,215-609-9,Black,,,,"Purity > 97 %, with the following impurity profile:
|
136
|
+
Ash content ≤ 0,15 %, total sulphur ≤ 0,65 %, total PAH ≤ 500 ppb and benzo(a)pyrene ≤ 5 ppb, dibenz(a,h)anthracene ≤ 5 ppb, total As ≤ 3 ppm, total Pb ≤ 10 ppm, total Hg ≤ 1 ppm.
|
137
|
+
|
138
138
|
","(EC) 2016/1120",,,"Carbon black","CI 77266",,14/08/2020
|
139
139
|
127,"Charcoal, bone. A fine black powder obtained by burning animal bones in a closed container. It consists primarily of calcium phosphate and carbon","CI 77267",8021-99-6,232-421-2,Black,,,,,"(EC) 2009/1223",,,Charcoal,"CI 77267",,14/08/2020
|
140
140
|
128,"Coke black","CI 77268:1","7440-44-0; 1339-82-8","231-153-3; 215-669-6",Black,,,,,"(EC) 2009/1223",,,"Coke black","CI 77268:1",,14/08/2020
|
@@ -152,10 +152,10 @@ Ash content ≤ 0,15 %, total sulphur ≤ 0,65 %, total PAH ≤ 500 ppb and benz
|
|
152
152
|
140,"Ammonium manganese(3+) diphosphate","CI 77742",10101-66-3,233-257-4,Violet,,,,,"(EC) 2009/1223",,,"Ammonium manganese(3+) diphosphate","CI 77742",,14/08/2020
|
153
153
|
141,"Trimanganese bis(orthophosphate)","CI 77745",10124-54-6,233-341-0,Red,,,,,"(EC) 2009/1223",,,"Trimanganese bis(orthophosphate)","CI 77745",,14/08/2020
|
154
154
|
142,Silver,"CI 77820",-,231-131-3,White,,,,"Purity criteria as set out in Commission Directive 95/45/EC (E174)","(EC) 2009/1223",,,,"CI 77820",,18/10/2010
|
155
|
-
143,"Titanium Dioxide/CI 77891","TITANIUM DIOXIDE/CI 77891",13463-67-7,236-675-5,White,,,,"— Purity criteria as set out in Commission Directive 95/45/E (E 171)
|
156
|
-
|
157
|
-
— Titanium dioxide in powder form containing 1 % or more of particles with aerodynamic diameter ≤ 10 μm, to be used in compliance with Annex III, No 321
|
158
|
-
|
155
|
+
143,"Titanium Dioxide/CI 77891","TITANIUM DIOXIDE/CI 77891",13463-67-7,236-675-5,White,,,,"— Purity criteria as set out in Commission Directive 95/45/E (E 171)
|
156
|
+
|
157
|
+
— Titanium dioxide in powder form containing 1 % or more of particles with aerodynamic diameter ≤ 10 μm, to be used in compliance with Annex III, No 321
|
158
|
+
|
159
159
|
(For use as a UV filter, see Annex VI, No 27)","(EC) 2009/1223",,,"Titanium Dioxide",,,21/06/2021
|
160
160
|
144,"Zinc oxide","ZINC OXIDE",1314-13-2,215-222-5,White,,,," Not to be used in applications that may lead to exposure of the end-user's lungs by inhalation. ","(EU) 2017/1413",,,"Zinc oxide","ZINC OXIDE,CI 77947",,18/10/2021
|
161
161
|
145,Riboflavin,"LACTOFLAVIN / RIBOFLAVIN",-,"201-507-1 / 204-988-6",Yellow,,,,"Purity criteria as set out in Commission Directive 95/45/EC (E101)","(EC) 2009/1223",,,"1-deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)-D-ribitol","LACTOFLAVIN,RIBOFLAVIN",,14/08/2020
|
data/data/annex.V.csv
CHANGED
@@ -1,87 +1,87 @@
|
|
1
1
|
reference_number,inn,common_ingredients,cas_number,ec_number,product_type,maximum_concentration,other,wording_of_conditions,regulation,regulated_by,other_regulations,sccs_opinions,chemical_name,identified_ingredients,cmr,update_date
|
2
2
|
1a,"Salts of benzoic acid other than that listed under reference number 1 and esters of benzoic acid","AMMONIUM BENZOATE / BUTYL BENZOATE / CALCIUM BENZOATE / ETHYL BENZOATE / ISOBUTYL BENZOATE / ISOPROPYL BENZOATE / MAGNESIUM BENZOATE / MEA-BENZOATE / METHYL BENZOATE / PHENYL BENZOATE / POTASSIUM BENZOATE / PROPYL BENZOATE","1863-63-4 /2090-05-3 / 582-25-2 / 553-70-8 / 4337-66-0 / 93-58-3 / 93-89-0 / 2315-68-6 / 136-60-7 / 1205-50-3 / 939-48-0 / 93-99-2","217-468-9 / 218-235-4 / 209-481-3 / 209-045-2 / 224-387-2 / 202-259-7 / 202-284-3 / 219-020-8 / 205-252-7 / 204-401-3 / 213-361-6 / 202-293-2",,"0.5% (acid)",,,"(EC) 2009/1223",,,,"BUTYL BENZOATE,AMMONIUM BENZOATE,CALCIUM BENZOATE,ETHYL BENZOATE,ISOBUTYL BENZOATE,ISOPROPYL BENZOATE,MAGNESIUM BENZOATE,MEA-BENZOATE,METHYL BENZOATE,PHENYL BENZOATE,POTASSIUM BENZOATE,PROPYL BENZOATE",,16/10/2010
|
3
|
-
1,"Benzoic acid and its sodium salt","BENZOIC ACID; SODIUM BENZOATE","65-85-0 / 532-32-1","200-618-2 / 208-534-8","a) Rinse-off products, except oral care products
|
4
|
-
b) Oral care products
|
5
|
-
c) Leave-on products","a) 2.5% (acid)
|
6
|
-
b) 1.7% (acid)
|
7
|
-
c) 0.5% (acid)
|
3
|
+
1,"Benzoic acid and its sodium salt","BENZOIC ACID; SODIUM BENZOATE","65-85-0 / 532-32-1","200-618-2 / 208-534-8","a) Rinse-off products, except oral care products
|
4
|
+
b) Oral care products
|
5
|
+
c) Leave-on products","a) 2.5% (acid)
|
6
|
+
b) 1.7% (acid)
|
7
|
+
c) 0.5% (acid)
|
8
8
|
",,,"(EC) 2009/1223",,"Opinion concerning Restrictions on Materials listed in annex VI of Directive 76/768/EEC on Cosmetic Products,Opinion on Benzoic Acid and Sodium Benzoate,Opinion on Benzoic Acid and Sodium Benzoate",,"BENZOIC ACID,SODIUM BENZOATE",,25/10/2010
|
9
9
|
2,"Propionic acid and its salts","PROPIONIC ACID / AMMONIUM PROPIONATE / CALCIUM PROPIONATE / MAGNESIUM PROPIONATE / POTASSIUM PROPIONATE / SODIUM PROPIONATE","79-09-4 / 17496-08-1 / 4075-81-4 / 557-27-7 / 327-62-8 / 137-40-6","201-176-3 / 241-503-7 / 223-795-8 / 209-166-0 / 206-323-5 / 205-290-4",,"2% (acid)",,,"(EC) 2009/1223",,"Opinion concerning Restrictions on Materials listed in annex VI of Directive 76/768/EEC on Cosmetic Products",,"AMMONIUM PROPIONATE,CALCIUM PROPIONATE,MAGNESIUM PROPIONATE,POTASSIUM PROPIONATE,PROPIONIC ACID,SODIUM PROPIONATE",,16/10/2010
|
10
|
-
3,"Salicylic acid and its salts","SALICYLIC ACID, CALCIUM SALICYLATE, MAGNESIUM SALICYLATE, MEA- SALICYLATE, SODIUM SALICYLATE, POTASSIUM SALICYLATE, TEA- SALICYLATE","69-72-7[1]/ 824-35-1[2]/ 18917-89-0[3]/ 59866-70-5[4]/ 54-21-7[5]/ 578-36-9[6]/ 2174-16-5[7]","200-712-3[1]/ 212-525-4[2]/ 242-669-3[3]/ 261-963-2[4]/ 200-198-0[5]/ 209-421-6[6]/ 218-531-3[7]",,"Salicylic acid: 0,5 % (acid)
|
11
|
-
|
12
|
-
Salicylic acid salts: 0,5 % (acid)
|
13
|
-
|
14
|
-
","Salicylic acid:
|
15
|
-
|
16
|
-
Not to be used in products for children under 3 years of age.
|
17
|
-
Not to be used in oral products.
|
18
|
-
Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation.
|
19
|
-
|
20
|
-
|
21
|
-
Salicylic acid salts:
|
22
|
-
|
23
|
-
Not to be used in products for children under 3 years of age, except for shampoos.","Salicylic acid:
|
24
|
-
Not to be used for children under 3 years of age**
|
25
|
-
**Solely for products which might be used for children under 3 years of age.
|
26
|
-
|
27
|
-
Salicylic acid salts:
|
28
|
-
Not to be used for children under 3 years of age***
|
10
|
+
3,"Salicylic acid and its salts","SALICYLIC ACID, CALCIUM SALICYLATE, MAGNESIUM SALICYLATE, MEA- SALICYLATE, SODIUM SALICYLATE, POTASSIUM SALICYLATE, TEA- SALICYLATE","69-72-7[1]/ 824-35-1[2]/ 18917-89-0[3]/ 59866-70-5[4]/ 54-21-7[5]/ 578-36-9[6]/ 2174-16-5[7]","200-712-3[1]/ 212-525-4[2]/ 242-669-3[3]/ 261-963-2[4]/ 200-198-0[5]/ 209-421-6[6]/ 218-531-3[7]",,"Salicylic acid: 0,5 % (acid)
|
11
|
+
|
12
|
+
Salicylic acid salts: 0,5 % (acid)
|
13
|
+
|
14
|
+
","Salicylic acid:
|
15
|
+
|
16
|
+
Not to be used in products for children under 3 years of age.
|
17
|
+
Not to be used in oral products.
|
18
|
+
Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation.
|
19
|
+
|
20
|
+
|
21
|
+
Salicylic acid salts:
|
22
|
+
|
23
|
+
Not to be used in products for children under 3 years of age, except for shampoos.","Salicylic acid:
|
24
|
+
Not to be used for children under 3 years of age**
|
25
|
+
**Solely for products which might be used for children under 3 years of age.
|
26
|
+
|
27
|
+
Salicylic acid salts:
|
28
|
+
Not to be used for children under 3 years of age***
|
29
29
|
***Solely for products which might be used for children under 3 years of age and which remain in prolonged contact with the skin.","(EU) 2019/1966",,"Opinion concerning Restrictions on Materials listed in annex VI of Directive 76/768/EEC on Cosmetic Products,Position paper on the Safety of alpha-Hydroxy Acids,Updated position paper concerning consumer Safety of alpha-hydroxy acids,OPINION ON salicylic acid (CAS 69-72-7) Submission I","Salicylic acid and its salts","SALICYLIC ACID,CALCIUM SALICYLATE,MAGNESIUM SALICYLATE,MEA-SALICYLATE,POTASSIUM SALICYLATE,SALICYLIC ACID,SODIUM SALICYLATE,TEA-SALICYLATE",,27/07/2020
|
30
30
|
4,"Hexa-2,4-dienoic acid and its salts","SORBIC ACID / CALCIUM SORBATE / SODIUM SORBATE / POTASSIUM SORBATE","110-44-1 / 7492-55-9 / 7757-81-5 / 24634-61-5","203-768-7 / 231-321-6 / 231-819-3 / 246-376-1",,"0.6% (acid)",,,"(EC) 2009/1223",,"Opinion concerning Restrictions on Materials listed in annex VI of Directive 76/768/EEC on Cosmetic Products",,"CALCIUM SORBATE,POTASSIUM SORBATE,SODIUM SORBATE,SORBIC ACID,TEA-SORBATE",,16/10/2010
|
31
31
|
6,"Moved or deleted",-,-,-,,,,,"(EC) 2009/1223",,,,,,03/10/2016
|
32
|
-
7,Biphenyl-2-ol,O-PHENYLPHENOL,90-43-7,201-993-5,,"The use of o-phenylphenol as a preservative should be allowed with a maximum concentration of 0,15 % (as phenol) in leave-on and 0,2 % (as phenol) in rinse-off cosmetic products.
|
33
|
-
Contact with eyes should be avoided.
|
32
|
+
7,Biphenyl-2-ol,O-PHENYLPHENOL,90-43-7,201-993-5,,"The use of o-phenylphenol as a preservative should be allowed with a maximum concentration of 0,15 % (as phenol) in leave-on and 0,2 % (as phenol) in rinse-off cosmetic products.
|
33
|
+
Contact with eyes should be avoided.
|
34
34
|
The use of sodium o-phenylphenate, potassium o-phenylphenate and MEA o-phenylphenate as preservatives should not be allowed.",,,"(EU) 2018/1847",,"ADDENDUM to the scientific opinion on o-Phenylphenol, Sodium o-phenylphenate and Potassium o-phenylphenate (SCCS/1555/15)",Biphenyl-2-ol,"O-PHENYLPHENOL,MEA O-PHENYLPHENATE,POTASSIUM O-PHENYLPHENATE,SODIUM O-PHENYLPHENATE",,28/07/2020
|
35
35
|
9,"Inorganic sulphites and hydrogensulphites (5)","SODIUM SULFITE / AMMONIUM BISULFITE / AMMONIUM SULFITE / POTASSIUM SULFITE / POTASSIUM hydrogen SULFITE / SODIUM BISULFITE / SODIUM METABISULFITE / POTASSIUM METABISULFITE","7757-83-7 / 10192-30-0 / 10196-04-0 / 10117-38-1 / 7773-03-7 / 7631-90-5 / 7681-57-4 / 16731-55-8","231-821-4 / 233-469-7 / 233-484-9 / 233-321-1 / 231-870-1 /231-548-0 / 231-673-0 / 240-795-3",,"0.2% (as free SO2)",,,"(EC) 2009/1223",,"Opinion concerning Restrictions on Materials listed in annex VI of Directive 76/768/EEC on Cosmetic Products",,",AMMONIUM BISULFITE,AMMONIUM SULFITE,POTASSIUM METABISULFITE,POTASSIUM SULFITE,SODIUM BISULFITE,SODIUM METABISULFITE,SODIUM SULFITE",,16/10/2010
|
36
36
|
10,"Moved or deleted",-,-,-,,,,,"(EC) 2009/1223",,,,,,03/10/2016
|
37
37
|
11,Chlorobutanol,CHLOROBUTANOL,57-15-8,200-317-6,,0.5%,"Not to be used in aerosol dispensers (sprays)","Contains Chlorobutanol","(EC) 2009/1223",,,"1,1,1-Trichloro-2-methyl-2-propanol",CHLOROBUTANOL,,16/10/2010
|
38
|
-
"12a","Butyl 4-hydroxybenzoate and its salts Propyl 4-hydroxybenzoate and its salts","BUTYLPARABEN/PROPYLPARABEN/SODIUM PROPOYLPARABEN/SODIUM BUTYLPARABEN/POTASSIUM BUTYLPARABEN/POTASSIUM PROPYLPARABEN","94-26-8/ 94-13-3/ 35285-69-9/ 36457-20-2/ 38566-94-8/ 84930-16-5","202-318-7/ 202-307-7/ 252-488-1/ 253-049-7/ 254-009-1/ 284-597-5",,"- 0,14% (as acid) for the sum of the individual concentrations
|
39
|
-
|
38
|
+
"12a","Butyl 4-hydroxybenzoate and its salts Propyl 4-hydroxybenzoate and its salts","BUTYLPARABEN/PROPYLPARABEN/SODIUM PROPOYLPARABEN/SODIUM BUTYLPARABEN/POTASSIUM BUTYLPARABEN/POTASSIUM PROPYLPARABEN","94-26-8/ 94-13-3/ 35285-69-9/ 36457-20-2/ 38566-94-8/ 84930-16-5","202-318-7/ 202-307-7/ 252-488-1/ 253-049-7/ 254-009-1/ 284-597-5",,"- 0,14% (as acid) for the sum of the individual concentrations
|
39
|
+
|
40
40
|
- 0,8% (as acid) for mixtures of substances mentioned in entry 12 and 12a, here the sum of the individual concentrations of butyl and propylparaben and their salts does not exceed 0,14%","Not to be used in leave-on products designed for application on the nappy area of children under three years of age.","For leave-on products designed for children under three years of age: ""Do not use on the nappy area""","(EC) 2014/1004",,"Extended Opinion on the Safety Evaluation of Parabens,Opinion on Parabens, underarm cosmetics and breast cancer,Opinion on Parabens,Opinion on Parabens,Opinion on Parabens,Opinion on Parabens updated request for a scientific opinion on 'propyl-and butylparaben',OPINION ON Propylparaben (PP)","Butyl 4-hydroxybenzoate and its salts Propyl 4-hydroxybenzoate and its salts (Butylparaben, propylparaben, sodium propylparaben, sodium butylparaben, potassium butylparaben, potassium propylparaben)","BUTYLPARABEN,POTASSIUM BUTYLPARABEN,POTASSIUM PROPYLPARABEN,PROPYLPARABEN,SODIUM BUTYLPARABEN,SODIUM PROPYLPARABEN",,02/08/2021
|
41
|
-
12,"4-Hydroxybenzoic acid and its Methyl- and Ethyl-esters, and their salts","4-HYDROXYBENZOIC ACID / METHYLPARABEN /POTASSIUM ETHYLPARABEN /POTASSIUM PARABEN /SODIUM METHYLPARABEN /SODIUM ETHYLPARABEN /ETHYLPARABEN /SODIUM PARABEN / POTASSIUM METHYLPARABEN / CALCIUM PARABEN","99-96-7 /99-76-3 /36457-19-9 /16782-08-4 /5026-62-0 /35285-68-8 /120-47-8 /114-63-6 /26112-0-2 /69959-44-0","202-804-9 /202-785-7 /253-048-1 /240-830-2 /225-714-1 /252-487-6 /204-399-4 /204-051-1 /247-464-2 /274-235-4",,"0,4% (as acid) for single ester
|
41
|
+
12,"4-Hydroxybenzoic acid and its Methyl- and Ethyl-esters, and their salts","4-HYDROXYBENZOIC ACID / METHYLPARABEN /POTASSIUM ETHYLPARABEN /POTASSIUM PARABEN /SODIUM METHYLPARABEN /SODIUM ETHYLPARABEN /ETHYLPARABEN /SODIUM PARABEN / POTASSIUM METHYLPARABEN / CALCIUM PARABEN","99-96-7 /99-76-3 /36457-19-9 /16782-08-4 /5026-62-0 /35285-68-8 /120-47-8 /114-63-6 /26112-0-2 /69959-44-0","202-804-9 /202-785-7 /253-048-1 /240-830-2 /225-714-1 /252-487-6 /204-399-4 /204-051-1 /247-464-2 /274-235-4",,"0,4% (as acid) for single ester
|
42
42
|
0,8% (as acid) for mixtures of esters",,,"(EC) 2014/1004",,"Opinion concerning Restrictions on Materials listed in annex VI of Directive 76/768/EEC on Cosmetic Products,Extended Opinion on the Safety Evaluation of Parabens,Opinion on Parabens, underarm cosmetics and breast cancer,Opinion on Parabens,Opinion on Parabens,Opinion on Parabens","4-Hydroxybenzoic acid and its Methyl- and Ethyl-esters, and their salts (4-Hydroxybenzoic acid, methylparaben, potassium ethylparaben, potassium paraben, sodium methylparaben, sodium ethylparaben, ethylparaben, sodium paraben, potassium methylparaben, calcium paraben)","4-HYDROXYBENZOIC ACID,CALCIUM PARABEN,ETHYLPARABEN,METHYLPARABEN,POTASSIUM ETHYLPARABEN,POTASSIUM METHYLPARABEN,POTASSIUM PARABEN,SODIUM ETHYLPARABEN,SODIUM METHYLPARABEN,SODIUM PARABEN",,11/08/2020
|
43
43
|
13,"3-Acetyl-6-methylpyran-2,4(3H)-dione and its salts","Dehydroacetic acid / SODIUM DEHYDROACETATE","520-45-6 / 4418-26-2 / 16807-48-0","208-293-9 / 224-580-1 / -",,"0.6% (as acid)","Not to be used in aerosol dispensers (sprays)",,"(EC) 2009/1223",,,,"DEHYDROACETIC ACID,SODIUM DEHYDROACETATE",,16/10/2010
|
44
44
|
14,"Formic acid and its sodium salt","FORMIC ACID / SODIUM FORMATE","64-18-6 / 141-53-7","200-579-1 / 205-488-0",,"0.5% (as acid)",,,"(EC) 2009/1223",,"Opinion concerning Restrictions on Materials listed in annex VI of Directive 76/768/EEC on Cosmetic Products",,"FORMIC ACID,SODIUM FORMATE",,16/10/2010
|
45
45
|
15,"3,3'-Dibromo-4,4'-hexamethylenedioxydibenzamidine and its salts (including isethionate)","Dibromohexamidine isethionate",93856-83-8,299-116-4,,0.1%,,,"(EC) 2009/1223",,,,"DIBROMOHEXAMIDINE ISETHIONATE",,16/10/2010
|
46
|
-
16,Thiomersal,THIMEROSAL,54-64-8,200-210-4,"Eye products","0.007% (of Hg)
|
46
|
+
16,Thiomersal,THIMEROSAL,54-64-8,200-210-4,"Eye products","0.007% (of Hg)
|
47
47
|
If mixed with other mercurial compounds authorized by this Regulation, the maximum concentration of Hg remains fixed at 0.007%",,"Contains Thiomersal","(EC) 2009/1223",,,,THIMEROSAL,,16/10/2010
|
48
|
-
17,"Phenylmercuric salts (including borate)","PHENYL MERCURIC ACETATE / PHENYL MERCURIC BENZOATE","62-38-4 / 94-43-9","200-532-5 / 202-331-8","Eye products","0.007% (of Hg)
|
48
|
+
17,"Phenylmercuric salts (including borate)","PHENYL MERCURIC ACETATE / PHENYL MERCURIC BENZOATE","62-38-4 / 94-43-9","200-532-5 / 202-331-8","Eye products","0.007% (of Hg)
|
49
49
|
If mixed with other mercurial compounds authorized by this Directive, the maximum concentration of Hg remains fixed at 0.007%",,"Contains Phenylmercuric compounds","(EC) 2009/1223",,,,"PHENYL MERCURIC ACETATE,PHENYL MERCURIC BENZOATE,PHENYL MERCURIC BORATE,PHENYL MERCURIC BROMIDE,PHENYL MERCURIC CHLORIDE",,16/10/2010
|
50
50
|
18,"Undec-10-enoic acid and its salts","UNDECYLENIC ACID / POTASSIUM UNDECYLENATE / SODIUM UNDECYLENATE / CALCIUM UNDECYLENATE / MEA-UNDECYLENATE / TEA-UNDECYLENATE","112-38-9 / 6159-41-7 / 3398-33-2 / 1322-14-1 / 84471-25-0 / 56532-40-2","203-965-8 / - / 222-264-8 / 215-331-8 / 282-908-9 / 260-247-7",,"0.2% (as acid)",,,"(EC) 2009/1223",,"Opinion concerning Restrictions on Materials listed in annex VI of Directive 76/768/EEC on Cosmetic Products",,"CALCIUM UNDECYLENATE,MEA-UNDECYLENATE,POTASSIUM UNDECYLENATE,SODIUM UNDECYLENATE,TEA-UNDECYLENATE,UNDECYLENIC ACID",,16/10/2010
|
51
51
|
19,"5-Pyrimidinamine, 1,3-bis(2-ethylhexyl)hexahydro-5-methyl-",Hexetidine,141-94-6,205-513-5,,0.1%,,,"(EC) 2009/1223",,"Opinion concerning Restrictions on Materials listed in annex VI of Directive 76/768/EEC on Cosmetic Products,Opinion on The Determination of certain Formaldehyde Releasers in Cosmetic Products",,HEXETIDINE,,16/10/2010
|
52
52
|
20,"5-Bromo-5-nitro-1,3-dioxane","5-BROMO-5-NITRO-1,3-DIOXANE",30007-47-7,250-001-7,"Rinse-off products",0.1%,"Avoid formation of nitrosamines",,"(EC) 2009/1223",,"Opinion on The Determination of certain Formaldehyde Releasers in Cosmetic Products,SCIENTIFIC ADVICE ON the threshold for the warning ‘contains formaldehyde’ in Annex V, preamble point 2 for formaldehyde-releasing substances","5-Bromo-5-nitro-1,3-dioxane","5-BROMO-5-NITRO-1,3-DIOXANE",,02/08/2021
|
53
53
|
21,Bronopol,"2-BROMO-2-NITROPROPANE-1,3-DIOL",52-51-7,200-143-0,,0.1%,"Avoid formation of nitrosamines",,"(EC) 2009/1223",,"Opinion concerning Restrictions on Materials listed in annex VI of Directive 76/768/EEC on Cosmetic Products,Opinion on The Determination of certain Formaldehyde Releasers in Cosmetic Products,SCIENTIFIC ADVICE ON the threshold for the warning ‘contains formaldehyde’ in Annex V, preamble point 2 for formaldehyde-releasing substances","2-Bromo-2-nitropropane-1,3-diol","2-BROMO-2-NITROPROPANE-1,3-DIOL",,02/08/2021
|
54
54
|
22,"2,4-Dichlorobenzyl alcohol","DICHLOROBENZYL ALCOHOL",1777-82-8,217-210-5,,0.15%,,,"(EC) 2009/1223",,"Opinion concerning Restrictions on Materials listed in annex VI of Directive 76/768/EEC on Cosmetic Products,Opinion on 2,4-Dichlorobenzyl Alcohol (DCBA)",,"DICHLOROBENZYL ALCOHOL",,16/10/2010
|
55
|
-
23,"1-(4-Chlorophenyl)-3-(3,4-dichlorophenyl)urea (6)",TRICLOCARBAN,101-20-2,202-924-1,,0.2%,"Purity criteria:
|
55
|
+
23,"1-(4-Chlorophenyl)-3-(3,4-dichlorophenyl)urea (6)",TRICLOCARBAN,101-20-2,202-924-1,,0.2%,"Purity criteria:
|
56
56
|
3, 3', 4, 4'-Tetrachloroazobenzene",,"(EC) 2009/1223",,"Opinion concerning Restrictions on Materials listed in annex VI of Directive 76/768/EEC on Cosmetic Products",,"TRICLOCARBAN,TRICLOCARBAN",,25/10/2010
|
57
57
|
24,Chlorocresol,P-CHLORO-M-CRESOL,59-50-7,200-431-6,"Not to be used in products applied on mucous membranes",0.2%,,,"(EC) 2009/1223",,"Opinion concerning Restrictions on Materials listed in annex VI of Directive 76/768/EEC on Cosmetic Products",,P-CHLORO-M-CRESOL,,25/10/2010
|
58
|
-
25,"5-Chloro-2-(2,4-dichlorophenoxy)phenol",TRICLOSAN,3380-34-5,222-182-2,"(a) Toothpastes Hand soaps Body soaps/ Shower gels Deodorants (non-spray) Face powders and blemish concealers Nail products for cleaning the fingernails and toenails before the application of artificial nail systems.
|
59
|
-
|
60
|
-
(b) Mouthwashes","(a) 0.3%
|
61
|
-
|
58
|
+
25,"5-Chloro-2-(2,4-dichlorophenoxy)phenol",TRICLOSAN,3380-34-5,222-182-2,"(a) Toothpastes Hand soaps Body soaps/ Shower gels Deodorants (non-spray) Face powders and blemish concealers Nail products for cleaning the fingernails and toenails before the application of artificial nail systems.
|
59
|
+
|
60
|
+
(b) Mouthwashes","(a) 0.3%
|
61
|
+
|
62
62
|
(b) 0.2%",,,"(EU) 2014/358",,"Opinion concerning Triclosan,Opinion on Triclosan,Opinion on Triclosan,Opinion on Triclosan Anti-microbial Resistance","5-Chloro-2-(2,4-dichlorophenoxy)phenol",TRICLOSAN,,11/08/2020
|
63
63
|
26,Chloroxylenol,CHLOROXYLENOL,"88-04-0 / 1321-23-9","201-793-8 / 215-316-6",,0.5%,,,"(EC) 2009/1223",,"Opinion concerning Restrictions on Materials listed in annex VI of Directive 76/768/EEC on Cosmetic Products","Phenol, 4-chloro-3,5-dimethyl-",CHLOROXYLENOL,,16/10/2010
|
64
64
|
27,"N,N''-Methylenebis[N'-[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]urea]","IMIDAZOLIDINYL UREA",39236-46-9,254-372-6,,0.6%,,,"(EC) 2009/1223",,"Opinion concerning Restrictions on Materials listed in annex VI of Directive 76/768/EEC on Cosmetic Products,Opinion on The Determination of certain Formaldehyde Releasers in Cosmetic Products,SCIENTIFIC ADVICE ON the threshold for the warning ‘contains formaldehyde’ in Annex V, preamble point 2 for formaldehyde-releasing substances","N,N''-Methylenebis[N'-[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]urea]","IMIDAZOLIDINYL UREA",,02/08/2021
|
65
|
-
28,"Polyhexamethylene biguanide hydrochloride","POLYAMINOPROPYL BIGUANIDE","32289-58-0 [1]/ 27083-27-8 [2]/ 28757-47-3 [3]/ 133029-32-0 [4]","608-723-9 [1]/ 608-042-7 [2]",,0.1%,"Not to be used in applications that may lead to exposure of the end-user's lungs by inhalation",,"(EU) 2019/831",,"Opinion concerning Restrictions on Materials listed in annex VI of Directive 76/768/EEC on Cosmetic Products,Opinion on the safety of poly(hexamethylene) biguanide hydrochloride (PHMB). (Revision of 16 December 2014) - CAS number have been added. Corrigendum (02/02/2016) test concentrations (last paragraph) on page 25 have been corrected,OPINION ON Polyaminopropyl Biguanide (PHMB) - Submission III","Polyhexamethylene biguanide hydrochloride
|
65
|
+
28,"Polyhexamethylene biguanide hydrochloride","POLYAMINOPROPYL BIGUANIDE","32289-58-0 [1]/ 27083-27-8 [2]/ 28757-47-3 [3]/ 133029-32-0 [4]","608-723-9 [1]/ 608-042-7 [2]",,0.1%,"Not to be used in applications that may lead to exposure of the end-user's lungs by inhalation",,"(EU) 2019/831",,"Opinion concerning Restrictions on Materials listed in annex VI of Directive 76/768/EEC on Cosmetic Products,Opinion on the safety of poly(hexamethylene) biguanide hydrochloride (PHMB). (Revision of 16 December 2014) - CAS number have been added. Corrigendum (02/02/2016) test concentrations (last paragraph) on page 25 have been corrected,OPINION ON Polyaminopropyl Biguanide (PHMB) - Submission III","Polyhexamethylene biguanide hydrochloride
|
66
66
|
","POLYAMINOPROPYL BIGUANIDE","Carcinogenic Cat. 2()",28/07/2020
|
67
67
|
29,2-Phenoxyethanol,PHENOXYETHANOL,122-99-6,204-589-7,,1.0%,,,"(EC) 2009/1223",,"Opinion concerning Restrictions on Materials listed in annex VI of Directive 76/768/EEC on Cosmetic Products,OPINION ON Phenoxyethanol",2-Phenoxyethanol,PHENOXYETHANOL,,28/07/2020
|
68
68
|
30,Methenamine,METHENAMINE,100-97-0,202-905-8,,0.15%,,,"(EC) 2009/1223",,"Opinion concerning Restrictions on Materials listed in annex VI of Directive 76/768/EEC on Cosmetic Products,Opinion on The Determination of certain Formaldehyde Releasers in Cosmetic Products,SCIENTIFIC ADVICE ON the threshold for the warning ‘contains formaldehyde’ in Annex V, preamble point 2 for formaldehyde-releasing substances","1,3,5,7-Tetraazatricyclo[3.3.1.1(3,7)]decane",METHENAMINE,,02/08/2021
|
69
|
-
32,"1-(4-Chlorophenoxy)-1-(imidazol-1-yl)-3,3-dimethylbutan-2-one",CLIMBAZOLE,38083-17-9,253-775-4,"(a) Hair lotions
|
70
|
-
(b) Face creams
|
71
|
-
(c) Foot care products
|
72
|
-
(d) Rinse-off shampoo","(a) 0,2 %
|
73
|
-
(b) 0,2 %
|
74
|
-
(c) 0,2 %
|
69
|
+
32,"1-(4-Chlorophenoxy)-1-(imidazol-1-yl)-3,3-dimethylbutan-2-one",CLIMBAZOLE,38083-17-9,253-775-4,"(a) Hair lotions
|
70
|
+
(b) Face creams
|
71
|
+
(c) Foot care products
|
72
|
+
(d) Rinse-off shampoo","(a) 0,2 %
|
73
|
+
(b) 0,2 %
|
74
|
+
(c) 0,2 %
|
75
75
|
(d) 0,5 %",,,"(EU) 2019/698",,"Opinion concerning Restrictions on Materials listed in annex VI of Directive 76/768/EEC on Cosmetic Products,Opinion concerning Azole Antimycotic Resistance,Opinion on Climbazole,Opinion on Climbazole,ADDENDUM to the scientific Opinions on Climbazole (P64) ref. SCCS/1506/13 and SCCS/1590/17","(R,S)-1-(4-chlorophenoxy)-1-imidazol-1-yl-3,3-dimethylbutan-2-one",CLIMBAZOLE,,28/07/2020
|
76
76
|
33,"1,3-Bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione","DMDM HYDANTOIN",6440-58-0,229-222-8,,0.6%,,,"(EC) 2009/1223",,"Opinion concerning Restrictions on Materials listed in annex VI of Directive 76/768/EEC on Cosmetic Products,Opinion on The Determination of certain Formaldehyde Releasers in Cosmetic Products,SCIENTIFIC ADVICE ON the threshold for the warning ‘contains formaldehyde’ in Annex V, preamble point 2 for formaldehyde-releasing substances","1,3-Bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione","DMDM HYDANTOIN",,02/08/2021
|
77
77
|
34,"Benzyl alcohol (7)","BENZYL ALCOHOL",100-51-6,202-859-9,,1.0%,,,"(EC) 2013/344",,,,"BENZYL ALCOHOL ,BENZYL ALCOHOL",,26/07/2013
|
78
|
-
35,"1-Hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)-2 pyridon and its monoethanolamine salt","1-Hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)-2 pyridon, piroctone olamine","50650-76-5 / 68890-66-4","- / 272-574-2","a) Rinse-off products
|
79
|
-
b) Other products","a) 1.0%
|
78
|
+
35,"1-Hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)-2 pyridon and its monoethanolamine salt","1-Hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)-2 pyridon, piroctone olamine","50650-76-5 / 68890-66-4","- / 272-574-2","a) Rinse-off products
|
79
|
+
b) Other products","a) 1.0%
|
80
80
|
b) 0.5% ",,,"(EC) 2009/1223",,"Opinion concerning Restrictions on Materials listed in annex VI of Directive 76/768/EEC on Cosmetic Products,Opinion on Piroctone Olamine and its monoethanolamine salt",,"PIROCTONE OLAMINE",,16/10/2010
|
81
81
|
36,"Moved or deleted",-,-,-,,,,,"(EC) 2009/1223",,,,,,16/10/2010
|
82
82
|
37,"2,2'-Methylenebis(6-bromo-4-chlorophenol)",BROMOCHLOROPHENE,15435-29-7,239-446-8,,0.1%,,,"(EC) 2009/1223",,"Opinion concerning Restrictions on Materials listed in annex VI of Directive 76/768/EEC on Cosmetic Products","6,6-Dibromo-4,4-dichloro-2,2'-methylene-diphenol",BROMOCHLOROPHENE,,25/10/2010
|
83
83
|
38,4-Isopropyl-m-cresol,O-CYMEN-5-OL,3228-02-2,221-761-7,,0.1%,,,"(EC) 2009/1223",,,,"ISOPROPYL CRESOLS,O-CYMEN-5-OL",,16/10/2010
|
84
|
-
39,"Mixture of 5-Chloro-2-methyl-isothiazol-3(2H)-one and 2-Methylisothiazol-3(2H)-one with magnesium chloride and magnesium nitrate","METHYLCHLOROISOTHIAZOLINONE AND METHYLISOTHIAZOLINONE","26172-55-4, 2682-20-4, 55965-84-9","247-500-7, 220-239-6",Rinse-off,"0.0015% (of a mixture in the ratio 3:1 of 5-Chloro-2-methyl-isothiazol-3(2H)-one and 2-Methylisothiazol-3(2H)-one",,,"(EC) 2014/1003",,"Opinion concerning Update of Entry no 39 of Annex VI to Directive 76/768/EEC on Cosmetic Products: Mixture of 5-Chloro-2-methyl-isothiazolin-3(2H)-one and 2-Methylisothiazolin-3(2H)-one,Clarification of the SCCNFP Opinion on the Update of Entry no. 39 of Annex VI to Directive 76/768/EEC on Cosmetic Products: Mixture of 5-Chloro-2-methyl-isothiazolin-3(2H)-one and 2-Methylisothiazolin-3(2H)-one,Opinion on Mixture of 5-chloro-2-methyl-isothiazolin-3(2H)-one and 2-methyl-isothiazolin-3(2H)-one,Opinion on Methylisothiazolinone (P94) (Sensitisation only)
|
84
|
+
39,"Mixture of 5-Chloro-2-methyl-isothiazol-3(2H)-one and 2-Methylisothiazol-3(2H)-one with magnesium chloride and magnesium nitrate","METHYLCHLOROISOTHIAZOLINONE AND METHYLISOTHIAZOLINONE","26172-55-4, 2682-20-4, 55965-84-9","247-500-7, 220-239-6",Rinse-off,"0.0015% (of a mixture in the ratio 3:1 of 5-Chloro-2-methyl-isothiazol-3(2H)-one and 2-Methylisothiazol-3(2H)-one",,,"(EC) 2014/1003",,"Opinion concerning Update of Entry no 39 of Annex VI to Directive 76/768/EEC on Cosmetic Products: Mixture of 5-Chloro-2-methyl-isothiazolin-3(2H)-one and 2-Methylisothiazolin-3(2H)-one,Clarification of the SCCNFP Opinion on the Update of Entry no. 39 of Annex VI to Directive 76/768/EEC on Cosmetic Products: Mixture of 5-Chloro-2-methyl-isothiazolin-3(2H)-one and 2-Methylisothiazolin-3(2H)-one,Opinion on Mixture of 5-chloro-2-methyl-isothiazolin-3(2H)-one and 2-methyl-isothiazolin-3(2H)-one,Opinion on Methylisothiazolinone (P94) (Sensitisation only)
|
85
85
|
Submission II","Mixture of 5-Chloro-2-methyl-isothiazol-3(2H)-one and 2-Methylisothiazol-3(2H)-one with magnesium chloride and magnesium nitrate","METHYLCHLOROISOTHIAZOLINONE,METHYLISOTHIAZOLINONE",,28/09/2022
|
86
86
|
42,"N,N'-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine and its digluconate, diacetate and dihydrochloride","CHLORHEXIDINE / CHLORHEXIDINE DIACETATE / CHLORHEXIDINE DIGLUCONATE / CHLORHEXIDINE DIHYDROCHLORIDE","55-56-1 / 56-95-1 / 18472-51-0 / 3697-42-5","200-238-7 / 200-302-4 / 242-354-0 / 223-026-6",,"0.3% (as chlorhexidine)",,,"(EC) 2009/1223",,"Opinion concerning Restrictions on Materials listed in annex VI of Directive 76/768/EEC on Cosmetic Products",,"CHLORHEXIDINE,CHLORHEXIDINE DIACETATE,CHLORHEXIDINE DIGLUCONATE,CHLORHEXIDINE DIHYDROCHLORIDE",,16/10/2010
|
87
87
|
43,"1-Phenoxypropan-2-ol (8)",PHENOXYISOPROPANOL,770-35-4,212-222-7,"Only for rinse-off products",1.0%,,,"(EC) 2009/1223",,,,PHENOXYISOPROPANOL,,09/11/2010
|
@@ -93,32 +93,32 @@ Submission II","Mixture of 5-Chloro-2-methyl-isothiazol-3(2H)-one and 2-Methylis
|
|
93
93
|
49,"5-Ethyl-3,7-dioxa-1-azabicyclo[3.3.0] octane",7-ETHYLBICYCLOOXAZOLIDINE,7747-35-5,231-810-4,,0.3%,"Not to be used in oral products and in products applied on mucous membranes",,"(EC) 2009/1223",,"SCIENTIFIC ADVICE ON the threshold for the warning ‘contains formaldehyde’ in Annex V, preamble point 2 for formaldehyde-releasing substances","5-Ethyl-3,7-dioxa-1-azabicyclo[3.3.0] octane",7-ETHYLBICYCLOOXAZOLIDINE,,02/08/2021
|
94
94
|
50,"3-(p-Chlorophenoxy)-propane-1,2-diol",chlorphenesin,104-29-0,203-192-6,,0.3%,,,"(EC) 2009/1223",,,,CHLORPHENESIN,,16/10/2010
|
95
95
|
51,"Sodium hydroxymethylamino acetate","SODIUM HYDROXYMETHYLGLYCINATE",70161-44-3,274-357-8,,0.5%,"Not to be used if the maximum theoretical concentration of releasable formaldehyde, irrespective of the source, if the mixture as placed on the market is ≥ 0,1 % w/w",,"(EU) 2021/1902",,"Opinion on The Determination of certain Formaldehyde Releasers in Cosmetic Products,SCIENTIFIC ADVICE ON the threshold for the warning ‘contains formaldehyde’ in Annex V, preamble point 2 for formaldehyde-releasing substances","Sodium N-(hydroxymethyl)glycinate /Sodium hydroxymethylamino acetate","SODIUM HYDROXYMETHYLGLYCINATE,",,04/11/2021
|
96
|
-
52,"Silver chloride deposited on titanium dioxide","SILVER CHLORIDE",7783-90-6,232-033-3,,"0.004% (as AgCl)","20% AgCl (w/w) on TiO2.
|
96
|
+
52,"Silver chloride deposited on titanium dioxide","SILVER CHLORIDE",7783-90-6,232-033-3,,"0.004% (as AgCl)","20% AgCl (w/w) on TiO2.
|
97
97
|
Not to be used in products for children under 3 years of age, in oral products and in eye and lip products ",,"(EC) 2009/1223",,,,"SILVER CHLORIDE",,16/10/2010
|
98
|
-
53,"Benzenemethanaminium, N,N-dimethyl-N-[2-[2-[4-(1,1,3,3,-tetramethylbutyl)phenoxy]ethoxy]ethyl]-, chloride","Benzethonium Chloride",121-54-0,204-479-9,"a) Rinse-off products
|
99
|
-
b) Leave-on products other than oral products
|
98
|
+
53,"Benzenemethanaminium, N,N-dimethyl-N-[2-[2-[4-(1,1,3,3,-tetramethylbutyl)phenoxy]ethoxy]ethyl]-, chloride","Benzethonium Chloride",121-54-0,204-479-9,"a) Rinse-off products
|
99
|
+
b) Leave-on products other than oral products
|
100
100
|
",0.1%,,,"(EC) 2009/1223",,"Opinion on Benzethonium Chloride,Opinion on Benzethonium Chloride",,"BENZETHONIUM CHLORIDE",,16/10/2010
|
101
101
|
54,"Benzalkonium chloride, bromide and saccharinate (10)","BENZALKONIUM CHLORIDE / BENZALKONIUM BROMIDE / BENZALKONIUM SACCHARINATE","8001-54-5/ 63449-41-2 / 91080-29-4 / 68989-01-5 / 68424-85-1 / 68391-01-5 / 61789-71-7 / 85409-22-9","264-151-6 / 293-522-5 / 273-545-7 / 270-325-2 / 269-919-4 / 263-080-8 / 287-089-1",,"0.1% (as benzalkonium chloride)",,"Avoid contact with eyes","(EC) 2009/1223",,"Opinion concerning Restrictions on Materials listed in annex VI of Directive 76/768/EEC on Cosmetic Products",,"BENZALKONIUM CHLORIDE / BENZALKONIUM BROMIDE / BENZALKONIUM SACCHARINATE,BENZALKONIUM BROMIDE,BENZALKONIUM CHLORIDE,BENZALKONIUM SACCHARINATE,CETALKONIUM CHLORIDE,CETEARALKONIUM BROMIDE,COCOALKONIUM CHLORIDE,HYDROGENATED TALLOWALKONIUM CHLORIDE,LAURALKONIUM BROMIDE,LAURALKONIUM CHLORIDE,MYRISTALKONIUM CHLORIDE,MYRISTALKONIUM SACCHARINATE,STEARALKONIUM CHLORIDE,TALLOWALKONIUM CHLORIDE,,,,,,,",,16/10/2010
|
102
102
|
55,"Methanol, (phenylmethoxy)-",BENZYLHEMIFORMAL,14548-60-8,238-588-8,"Rinse-off products",0.15%,,,"(EC) 2009/1223",,"Opinion on The Determination of certain Formaldehyde Releasers in Cosmetic Products,Opinion on Benzylhemiformal,SCIENTIFIC ADVICE ON the threshold for the warning ‘contains formaldehyde’ in Annex V, preamble point 2 for formaldehyde-releasing substances","Benzyloxymethanol; benzyl hydroxyoxymethan",BENZYLHEMIFORMAL,,02/08/2021
|
103
|
-
56,3-Iodo-2-propynylbutylcarbamate,"IODOPROPYNYL BUTYLCARBAMATE",55406-53-6,259-627-5,"a) Rinse-off products
|
104
|
-
b) Leave-on products
|
105
|
-
c) Deodorants/antiperspirants","a) 0.02%
|
106
|
-
b) 0.01%
|
107
|
-
c) 0.0075%
|
108
|
-
","Not to be used in oral and lip products
|
109
|
-
a) Not to be used in products for children under 3 years of age, except in bath products / shower gels and shampoos
|
110
|
-
b) Not to be used in body lotion and body cream (13)
|
111
|
-
b) and c) Not to be used in products for children under 3 years of age
|
112
|
-
","a) Not to be used for children under three years of age (11)
|
113
|
-
b) and c) Not to be used for children under three years of age (12)
|
103
|
+
56,3-Iodo-2-propynylbutylcarbamate,"IODOPROPYNYL BUTYLCARBAMATE",55406-53-6,259-627-5,"a) Rinse-off products
|
104
|
+
b) Leave-on products
|
105
|
+
c) Deodorants/antiperspirants","a) 0.02%
|
106
|
+
b) 0.01%
|
107
|
+
c) 0.0075%
|
108
|
+
","Not to be used in oral and lip products
|
109
|
+
a) Not to be used in products for children under 3 years of age, except in bath products / shower gels and shampoos
|
110
|
+
b) Not to be used in body lotion and body cream (13)
|
111
|
+
b) and c) Not to be used in products for children under 3 years of age
|
112
|
+
","a) Not to be used for children under three years of age (11)
|
113
|
+
b) and c) Not to be used for children under three years of age (12)
|
114
114
|
","(EC) 2009/1223",,"Opinion on Iodopropynyl Butylcarbamate,Opinion on 3-Iodo-2-propynylbutylcarbamate (IBPC)",,"IODOPROPYNYL BUTYLCARBAMATE",,16/10/2010
|
115
115
|
57,2-Methyl-2H-isothiazol-3-one,METHYLISOTHIAZOLINONE,2682-20-4,220-239-6,,"0,0015 % Rinse-off products",,,"(EU) 2017/1224",,"Opinion on Methylisothiazolinone,Opinion on Methylisothiazolinone",2-Methyl-2H-isothiazol-3-one,METHYLISOTHIAZOLINONE,,27/07/2020
|
116
|
-
58,"Ethyl-N-alpha-dodecanoyl-L-arginate hydrochloride",-,60372-77-2,434-630-6,"(a) Mouthwashes
|
117
|
-
|
118
|
-
(b) Other products","(a) 0,15 %
|
119
|
-
|
120
|
-
(b) 0,4 %","(a) Not to be used in preparations for children under 10 years of age
|
121
|
-
|
116
|
+
58,"Ethyl-N-alpha-dodecanoyl-L-arginate hydrochloride",-,60372-77-2,434-630-6,"(a) Mouthwashes
|
117
|
+
|
118
|
+
(b) Other products","(a) 0,15 %
|
119
|
+
|
120
|
+
(b) 0,4 %","(a) Not to be used in preparations for children under 10 years of age
|
121
|
+
|
122
122
|
(b) Not to be used in lip products, oral products (other than mouthwashes), and spray products","(a) Not to be used for children under 10 years of age","(EU) 2016/1121",,"ADDENDUM to the Opinion on Ethyl lauroyl arginate HCl - SCCS/1519/13","Ethyl-N-alpha-dodecanoyl-L-arginate hydrochloride",,,27/07/2020
|
123
123
|
59,"1,2,3-Propanetricarboxylic acid, 2-hydroxy-, monohydrate and 1,2,3-Propanetricarboxylic acid, 2-hydroxy-silver(1+) salt, monohydrate","CITRIC ACID (AND) SILVER CITRATE","5949-29-1; 77-92-9; 36701-38-9",460-890-5,,"0,2% corresponding to 0,0024% of silver","Not to be used in oral producrs and eye products",,"(EU) 2014/866",,,"1,2,3-Propanetricarboxylic acid, 2-hydroxy-, monohydrate and 1,2,3-Propanetricarboxylic acid, 2-hydroxy-silver(1+) salt, monohydrate","CITRIC ACID,SILVER CITRATE",,06/08/2020
|
124
124
|
60,4-(3-ethoxy-4-hydroxyphenyl)butan-2-one,"HYDROXYETHOXYPHENYL BUTANONE, HEPB",569646-79-3,933-435-8,"Allowed for use as a preservative in rinse off, oral care and leave-on cosmetic products at a maximum concentration of 0,7 % in ready for use preparation.","0.7 %",,,"(EC) 2019/1858",,"OPINION ON Ethylzingerone - ‘Hydroxyethoxyphenyl Butanone’ (HEPB) - Cosmetics Europe No P98 – CAS No 569646-79-3 Submission II (eye irritation),OPINION ON Ethylzingerone –‘Hydroxyethoxyphenyl Butanone’ (HEPB)",4-(3-ethoxy-4-hydroxyphenyl)butan-2-one,,,27/07/2020
|
data/data/annex.VI.csv
CHANGED
@@ -1,25 +1,25 @@
|
|
1
1
|
reference_number,inn,common_ingredients,cas_number,ec_number,product_type,maximum_concentration,other,wording_of_conditions,regulation,regulated_by,other_regulations,sccs_opinions,chemical_name,identified_ingredients,cmr,update_date
|
2
2
|
2,"N,N,N-Trimethyl-4-(2-oxoborn-3-ylidenemethyl) anilinium methyl sulphate","Camphor benzalkonium methosulfate",52793-97-2,258-190-8,,6%,,,"(EC) 2009/1223",,"Opinion on Camphor benzalkonium methosulfate,Opinion on Camphor benzalkonium methosulfate",,"CAMPHOR BENZALKONIUM METHOSULFATE",,15/10/2010
|
3
3
|
3,"Benzoic acid, 2-hydroxy-, 3,3,5-trimethylcyclohexyl ester / Homosalate",HOMOSALATE,118-56-9,204-260-8,"Face products with the exception of propellent spray products","7,34 %","From 1 January 2025 cosmetic products containing that substance and not complying with the conditions shall not be placed on the Union market. From 1 July 2025 cosmetic products containing that substance and not complying with the conditions shall not be made available on the Union market.",,"(EC) 2009/1223",,"Opinion on Homosalate,OPINION on Homosalate,Scientific Advice on the safety of Homosalate (CAS No 118-56-9, EC No 204-260-8) as a UV-filter in cosmetic products","Benzoic acid, 2-hydroxy-, 3,3,5-trimethylcyclohexyl ester / Homosalate",HOMOSALATE,,11/11/2022
|
4
|
-
4,"2-Hydroxy-4-methoxybenzophenone / Oxybenzone",BENZOPHENONE-3,131-57-7,205-031-5,"a) Face products, hand products, and lip products, excluding propellant and pump spray products
|
5
|
-
b) Body products, including propellant and pump spray products
|
6
|
-
c) Other products","a) 6%
|
7
|
-
b) 2,2%
|
8
|
-
c) 0,5%
|
9
|
-
|
10
|
-
Footnote 1: However, cosmetic products containing '2-Hydroxy-4-methoxy-benzophenone/Oxybenzone' and complying with the restrictions set out in Regulation (EC) No 1223/2009 as applicable on 27 July 2022 may be placed on the Union market until 28 January 2023 and be made available on the Union market until 28 July 2023.","a) If used at 0,5 % to protect product formulation, the levels used as UV filter must not exceed 5,5 %.
|
11
|
-
b) If used at 0,5 % to protect product formulation, the levels used as UV filter must not exceed 1,7 %.","For a) and b): Contains Benzophenone-3 (*)
|
12
|
-
|
4
|
+
4,"2-Hydroxy-4-methoxybenzophenone / Oxybenzone",BENZOPHENONE-3,131-57-7,205-031-5,"a) Face products, hand products, and lip products, excluding propellant and pump spray products
|
5
|
+
b) Body products, including propellant and pump spray products
|
6
|
+
c) Other products","a) 6%
|
7
|
+
b) 2,2%
|
8
|
+
c) 0,5%
|
9
|
+
|
10
|
+
Footnote 1: However, cosmetic products containing '2-Hydroxy-4-methoxy-benzophenone/Oxybenzone' and complying with the restrictions set out in Regulation (EC) No 1223/2009 as applicable on 27 July 2022 may be placed on the Union market until 28 January 2023 and be made available on the Union market until 28 July 2023.","a) If used at 0,5 % to protect product formulation, the levels used as UV filter must not exceed 5,5 %.
|
11
|
+
b) If used at 0,5 % to protect product formulation, the levels used as UV filter must not exceed 1,7 %.","For a) and b): Contains Benzophenone-3 (*)
|
12
|
+
|
13
13
|
Footnote (*): Not required if concentration is 0,5 % or less and when it is used only for product protection purposes.","(EU) 2017/238",,"Evaluation of Potentially Estrogenic Effects of UV-filters,Opinion on Benzophenone-3,Opinion on Benzophenone-3,OPINION on Benzophenone-3","2-Hydroxy-4-methoxybenzophenone / Oxybenzone",BENZOPHENONE-3,,29/08/2022
|
14
14
|
5,"Moved or deleted",-,-,-,,,,,"(EC) 2009/1223",,,,,,03/10/2016
|
15
15
|
6,"2-Phenylbenzimidazole-5-sulphonic acid and its potassium, sodium and triethanolamine salts / Ensulizole","PHENYLBENZIMIDAZOLE SULFONIC ACID",27503-81-7,248-502-0,,"8%(as acid)",,,"(EC) 2009/1223",,"Opinion on Phenylbenzimidazole Sulfonic Acid and its salts",,"PHENYLBENZIMIDAZOLE SULFONIC ACID,POTASSIUM PHENYLBENZIMIDAZOLE SULFONATE,SODIUM PHENYLBENZIMIDAZOLE SULFONATE,TEA-PHENYLBENZIMIDAZOLE SULFONATE",,08/03/2011
|
16
16
|
7,"3,3'-(1,4-Phenylenedimethylene) bis (7,7-dimethyl-2-oxobicyclo-[2.2.1] hept-1-ylmethanesulfonic acid) and its salts / Ecamsule","TEREPHTHALYLIDENE DICAMPHOR SULFONIC ACID","92761-26-7 / 90457-82-2","410-960-6 / -",,"10%(as acid)",,,"(EC) 2009/1223",,,,"TEREPHTHALYLIDENE DICAMPHOR SULFONIC ACID",,26/10/2010
|
17
17
|
8,"1-(4-tert-Butylphenyl)-3-(4-methoxyphenyl) propane-1,3-dione / Avobenzone","Butyl Methoxydibenzoylmethane",70356-09-1,274-581-6,,5%,,,"(EC) 2009/1223",,,,"BUTYL METHOXYDIBENZOYLMETHANE",,15/10/2010
|
18
18
|
9,"alpha-(2-Oxoborn-3-ylidene)toluene-4-sulphonic acid and its salts","BENZYLIDENE CAMPHOR SULFONIC ACID",56039-58-8,-,,"6%(as acid)",,,"(EC) 2009/1223",,,,"BENZYLIDENE CAMPHOR SULFONIC ACID",,26/10/2010
|
19
|
-
10,"2-Cyano-3,3-diphenyl acrylic acid 2-ethylhexyl ester / Octocrilene",OCTOCRYLENE,6197-30-4,228-250-8,"a) Propellant spray products
|
20
|
-
b) Other products","a) 9%
|
21
|
-
b) 10%
|
22
|
-
|
19
|
+
10,"2-Cyano-3,3-diphenyl acrylic acid 2-ethylhexyl ester / Octocrilene",OCTOCRYLENE,6197-30-4,228-250-8,"a) Propellant spray products
|
20
|
+
b) Other products","a) 9%
|
21
|
+
b) 10%
|
22
|
+
|
23
23
|
Footnote (*3): Benzophenone as an impurity and/or degradation product of Octocrylene shall be kept at trace level.",,,"(EU) 2022/1176",,"OPINION on Octocrylene","2-Cyano-3,3-diphenyl acrylic acid 2-ethylhexyl ester / Octocrylene",OCTOCRYLENE,,31/01/2023
|
24
24
|
11,"Polymer of N-{(2 and 4)-[(2-oxoborn-3-ylidene)methyl]benzyl}acrylamide","POLYACRYLAMIDOMETHYL BENZYLIDENE CAMPHOR",113783-61-2,-,,6%,,,"(EC) 2009/1223",,,,"POLYACRYLAMIDOMETHYL BENZYLIDENE CAMPHOR",,26/10/2010
|
25
25
|
12,"2-Ethylhexyl 4-methoxycinnamate / Octinoxate","ETHYLHEXYL METHOXYCINNAMATE",5466-77-3,226-775-7,,10%,,,"(EC) 2009/1223",,"Evaluation of Potentially Estrogenic Effects of UV-filters","Ethylhexyl Methoxycinnamate is the ester of 2-ethylhexyl alcohol and methoxycinnamic acid.","ETHYLHEXYL METHOXYCINNAMATE",,18/07/2019
|
@@ -32,77 +32,77 @@ Footnote (*3): Benzophenone as an impurity and/or degradation product of Octocry
|
|
32
32
|
20,"2-Ethylhexyl salicylate / Octisalate)","ETHYLHEXYL SALICYLATE",118-60-5,204-263-4,,5%,,,"(EC) 2009/1223",,"Opinion on 2-Ethylhexyl salicylate",,"ETHYLHEXYL SALICYLATE",,08/03/2011
|
33
33
|
21,"2-Ethylhexyl 4-(dimethylamino)benzoate / Padimate O (USAN:BAN)","ETHYLHEXYL DIMETHYL PABA",21245-02-3,244-289-3,,8%,,,"(EC) 2009/1223",,"Opinion on 2-Ethylhexyl-4-dimethylaminobenzoate",,"ETHYLHEXYL DIMETHYL PABA",,26/10/2010
|
34
34
|
22,"2-Hydroxy-4-methoxybenzophenone-5-sulfonic acid (Benzophenone-5) and its sodium salt / Sulisobenzone","Benzophenone-4; Benzophenone-5","4065-45-6 / 6628-37-1","223-772-2 / -",,"5%(as acid)",,,"(EC) 2009/1223",,"Opinion on 2-Hydroxy-4-methoxybenzophenone-5-sulphonic acid",,"BENZOPHENONE-4,BENZOPHENONE-5",,15/10/2010
|
35
|
-
23a,"Methylene Bis-Benzotriazolyl Tetramethylbutylphenol (nano)","METHYLENE BIS-BENZOTRIAZOLYL TETRAMETHYLBUTYLPHENOL (NANO)",103597-45-1,403-800-1,,"10 %(*)
|
36
|
-
|
37
|
-
(*) In case of combined use of Methylene Bis-Benzotriazolyl Tetramethylbutylphenol and Methylene Bis-Benzotriazolyl Tetramethylbutylphenol (nano), the sum shall not exceed the limit given in column g.’.","Not to be used in applications that may lead to exposure of the end user's lungs by inhalation.
|
38
|
-
Only nanomaterials having the following characteristics are allowed:
|
39
|
-
— Purity ≥ 98,5 %, with 2,2′-methylene-bis- (6(2H-benzotriazol-2-yl)-4-(isooctyl)phenol) isomer fraction not exceeding 1,5 %;
|
40
|
-
— Solubility < 5 ng/L in water at 25 °C; — Partition coefficient (Log Pow): 12,7 at 25 °C;
|
41
|
-
— Uncoated;
|
42
|
-
— Median particle size D50 (50 % of the number below this diameter): ≥ 120 nm of mass distribution and/or ≥ 60 nm of number size distribution.",,"(EU) 2018/885",,"Opinion on 2,2'-Methylene-bis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol),Opinion on 2,2’-Methylene-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol) nano form (S79) Revision of 23 July 2013,Opinion on 2,2’-Methylene-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol) (nano form)","2,2′-Methylene-bis(6-(2H-benzotriazol-2-yl)-4- (1,1,3,3-tetramethylbutyl)phenol)/Bisoctrizole
|
35
|
+
23a,"Methylene Bis-Benzotriazolyl Tetramethylbutylphenol (nano)","METHYLENE BIS-BENZOTRIAZOLYL TETRAMETHYLBUTYLPHENOL (NANO)",103597-45-1,403-800-1,,"10 %(*)
|
36
|
+
|
37
|
+
(*) In case of combined use of Methylene Bis-Benzotriazolyl Tetramethylbutylphenol and Methylene Bis-Benzotriazolyl Tetramethylbutylphenol (nano), the sum shall not exceed the limit given in column g.’.","Not to be used in applications that may lead to exposure of the end user's lungs by inhalation.
|
38
|
+
Only nanomaterials having the following characteristics are allowed:
|
39
|
+
— Purity ≥ 98,5 %, with 2,2′-methylene-bis- (6(2H-benzotriazol-2-yl)-4-(isooctyl)phenol) isomer fraction not exceeding 1,5 %;
|
40
|
+
— Solubility < 5 ng/L in water at 25 °C; — Partition coefficient (Log Pow): 12,7 at 25 °C;
|
41
|
+
— Uncoated;
|
42
|
+
— Median particle size D50 (50 % of the number below this diameter): ≥ 120 nm of mass distribution and/or ≥ 60 nm of number size distribution.",,"(EU) 2018/885",,"Opinion on 2,2'-Methylene-bis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol),Opinion on 2,2’-Methylene-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol) nano form (S79) Revision of 23 July 2013,Opinion on 2,2’-Methylene-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol) (nano form)","2,2′-Methylene-bis(6-(2H-benzotriazol-2-yl)-4- (1,1,3,3-tetramethylbutyl)phenol)/Bisoctrizole
|
43
43
|
Methylene Bis- Benzotriazolyl Tetramethylbutylphenol (nano)",,,06/08/2020
|
44
44
|
23,"2,2'-Methylene bis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol) / Bisoctrizole","METHYLENE BIS-BENZOTRIAZOLYL TETRAMETHYLBUTYLPHENOL",103597-45-1,403-800-1,,10%,,,"(EU) 2018/885",,"Opinion on 2,2'-Methylene-bis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol),Opinion on 2,2’-Methylene-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol) nano form (S79) Revision of 23 July 2013,Opinion on 2,2’-Methylene-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol) (nano form)","2,2'-Methylene bis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol) / Bisoctrizole","METHYLENE BIS-BENZOTRIAZOLYL TETRAMETHYLBUTYLPHENOL",,27/07/2020
|
45
45
|
24,"Sodium salt of 2,2'-bis(1,4-phenylene)-1H-benzimidazole-4,6-disulfonic acid / Bisdisulizole disodium (USAN)","DISODIUM PHENYL DIBENZIMIDAZOLE TETRASULFONATE",180898-37-7,429-750-0,,"10%(as acid)",,,"(EC) 2009/1223",,"Opinion on 2,2'-(1,4-Phenylene)bis(1H-benzimidazole-4,6-disulfonic acid, monosodium salt)",,"DISODIUM PHENYL DIBENZIMIDAZOLE TETRASULFONATE",,26/10/2010
|
46
46
|
25,"2,2'-(6-(4-Methoxyphenyl)-1,3,5-triazine-2,4-diyl)bis(5-((2-ethylhexyl)oxy)phenol) / Bemotrizinol","BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE",187393-00-6,-,,10%,,,"(EC) 2009/1223",,"Opinion on 2,4-bis{[4-(2-Ethylhexyloxy)-2-hydroxy]-phenyl}-6-(4-methoxyphenyl)-(1,3,5)-triazine",,"BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE",,08/03/2011
|
47
47
|
26,Dimethicodiethylbenzalmalonate,Polysilicone-15,207574-74-1,426-000-4,,10%,,,"(EC) 2009/1223",,"Opinion on Benzylidine malonate polysiloxane,Opinion on Polysilicone-15",,POLYSILICONE-15,,15/10/2010
|
48
|
-
27a,"Titanium dioxide (nano)","TITANIUM DIOXIDE (NANO)","13463-67-7[1]/ 1317-70-0[2]/ 1317-80-2[3]","236-675-5[1] /215-280-1[2]/ 215-282-2[3]",,"25%
|
49
|
-
- In case of combined use of Titanium Dioxide and Titanium Dioxide (nano), the sum shall not exceed the limit of 25%.",,"Not to be used in applications that may lead to exposure of the end-user's lungs by inhalation
|
50
|
-
Only nanomaterials having the following characteristics are allowed:
|
51
|
-
— purity ≥ 99 %,
|
52
|
-
— rutile form, or rutile with up to 5 % anatase, with crystalline structure and physical appearance as clusters of spherical, needle, or lanceolate shapes,
|
53
|
-
— median particle size based on number size distribution ≥ 30 nm,
|
54
|
-
— aspect ratio from 1 to 4,5, and volume specific surface area ≤ 460 m2/cm3,
|
55
|
-
|
56
|
-
— coated with Silica, Hydrated Silica, Alumina, Aluminium Hydroxide, Aluminium Stearate, Stearic Acid, Trimethoxycaprylylsilane, Glycerin, Dimethicone, Hydrogen Dimethicone, Simethicone;
|
57
|
-
|
58
|
-
or coated with one of the following combinations:
|
59
|
-
—Silica at a maximum concentration of 16 % and Cetyl Phosphate at a maximum concentration of 6 %,
|
60
|
-
—Alumina at a maximum concentration of 7 % and Manganese Dioxide at a maximum concentration of 0,7 % (not to be used in lip products), —Alumina at a maximum concentration of 3 % and Triethoxycaprylylsilane at a maximum concentration of 9 %,
|
61
|
-
|
62
|
-
— photocatalytic activity ≤ 10 % compared to corresponding non-coated or non-doped reference,
|
63
|
-
— nanoparticles are photostable in the final formulation.
|
64
|
-
|
65
|
-
Wording of conditions of use and warnings:
|
66
|
-
For face products containing Titanium Dioxide (nano) coated with the combination Alumina and Manganese Dioxide: Not to be used on the lips.","(EU) 2019/1857",,"Opinion on Titanium Dioxide,Opinion for clarification of the meaning of the term ""sprayable
|
48
|
+
27a,"Titanium dioxide (nano)","TITANIUM DIOXIDE (NANO)","13463-67-7[1]/ 1317-70-0[2]/ 1317-80-2[3]","236-675-5[1] /215-280-1[2]/ 215-282-2[3]",,"25%
|
49
|
+
- In case of combined use of Titanium Dioxide and Titanium Dioxide (nano), the sum shall not exceed the limit of 25%.",,"Not to be used in applications that may lead to exposure of the end-user's lungs by inhalation
|
50
|
+
Only nanomaterials having the following characteristics are allowed:
|
51
|
+
— purity ≥ 99 %,
|
52
|
+
— rutile form, or rutile with up to 5 % anatase, with crystalline structure and physical appearance as clusters of spherical, needle, or lanceolate shapes,
|
53
|
+
— median particle size based on number size distribution ≥ 30 nm,
|
54
|
+
— aspect ratio from 1 to 4,5, and volume specific surface area ≤ 460 m2/cm3,
|
55
|
+
|
56
|
+
— coated with Silica, Hydrated Silica, Alumina, Aluminium Hydroxide, Aluminium Stearate, Stearic Acid, Trimethoxycaprylylsilane, Glycerin, Dimethicone, Hydrogen Dimethicone, Simethicone;
|
57
|
+
|
58
|
+
or coated with one of the following combinations:
|
59
|
+
—Silica at a maximum concentration of 16 % and Cetyl Phosphate at a maximum concentration of 6 %,
|
60
|
+
—Alumina at a maximum concentration of 7 % and Manganese Dioxide at a maximum concentration of 0,7 % (not to be used in lip products), —Alumina at a maximum concentration of 3 % and Triethoxycaprylylsilane at a maximum concentration of 9 %,
|
61
|
+
|
62
|
+
— photocatalytic activity ≤ 10 % compared to corresponding non-coated or non-doped reference,
|
63
|
+
— nanoparticles are photostable in the final formulation.
|
64
|
+
|
65
|
+
Wording of conditions of use and warnings:
|
66
|
+
For face products containing Titanium Dioxide (nano) coated with the combination Alumina and Manganese Dioxide: Not to be used on the lips.","(EU) 2019/1857",,"Opinion on Titanium Dioxide,Opinion for clarification of the meaning of the term ""sprayable
|
67
67
|
applications/products"" for the nano forms of Carbon Black CI 77266, Titanium Oxide and Zinc Oxide,OPINION ON Titanium Dioxide (nano form) as UV-Filter in sprays,OPINION ON Titanium Dioxide (nano form) coated with Cetyl Phosphate, Manganese Dioxide or Triethoxycaprylylsilane as UV-filter in dermally applied cosmetic","Titanium dioxide [1];Anatase (TiO2) [2];Rutile (TiO2) [3]",,,28/07/2020
|
68
|
-
27,"Titanium Dioxide","TITANIUM DIOXIDE","13463-67-7[1]/ 1317-70-0[2]/ 1317-80-2[3]","236-675-5[1] /215-280-1[2]/215-282-2 [ 3]",,"25%*
|
69
|
-
*: In case of combined use of Titanium Dioxide and Titanium Dioxide (nano), the sum shall not exceed the limit given in column g (Maximum concentration in ready for use preparation)","Titanium dioxide in powder form containing 1 % or more of particles with aerodynamic diameter ≤ 10 μm, to be used in compliance with Annex III, No 321. For the product types under letter (c) of column (f) in Annex III, No 321, the maximum concentration in ready for use preparation provided in column (g) of this entry applies.
|
70
|
-
|
68
|
+
27,"Titanium Dioxide","TITANIUM DIOXIDE","13463-67-7[1]/ 1317-70-0[2]/ 1317-80-2[3]","236-675-5[1] /215-280-1[2]/215-282-2 [ 3]",,"25%*
|
69
|
+
*: In case of combined use of Titanium Dioxide and Titanium Dioxide (nano), the sum shall not exceed the limit given in column g (Maximum concentration in ready for use preparation)","Titanium dioxide in powder form containing 1 % or more of particles with aerodynamic diameter ≤ 10 μm, to be used in compliance with Annex III, No 321. For the product types under letter (c) of column (f) in Annex III, No 321, the maximum concentration in ready for use preparation provided in column (g) of this entry applies.
|
70
|
+
|
71
71
|
(For use as a colourant, see Annex IV, No 143)",,"(EC) 2009/1223",,"Opinion on Titanium Dioxide,Titanium dioxide (TiO2) used in cosmetic products that lead to exposure by inhalation.","Titanium Dioxide",,,21/06/2021
|
72
72
|
28,"Benzoic acid, 2-[4-(diethylamino)-2-hydroxybenzoyl]-, hexylester","DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE",302776-68-7,443-860-6,,"10% ",,,"(EC) 2013/344",,"Opinion on Benzoic acid, 2-[4-(diethylamino)-2-hydroxybenzoyl]-,hexylester,Opinion on Benzoic Acid, 2-[4-(Diethylamino)-2-hydroxybenzoyl]-,hexylester,Opinion on Benzoic acid, 2-[4-(diethylamino)-2-hydroxybenzoyl]-, hexylester,Opinion on Diethylamino Hydroxybenzoyl Hexyl Benzoate",,"DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE",,29/07/2013
|
73
|
-
29,"1,3,5-Triazine, 2,4,6-tris(1,1'-biphenyl)-4-yl-, including as nanomaterial","TRIS-BIPHENYL TRIAZINE / TRIS-BIPHENYL TRIAZINE (NANO)",31274-51-8,-,,10%,"Not to be used in sprays.
|
74
|
-
Only nanomaterials having the folloing characteristics are allowed:
|
75
|
-
- Median primary particle size >80 nm;
|
76
|
-
- Purity ≥ 98%;
|
77
|
-
- Uncoated
|
73
|
+
29,"1,3,5-Triazine, 2,4,6-tris(1,1'-biphenyl)-4-yl-, including as nanomaterial","TRIS-BIPHENYL TRIAZINE / TRIS-BIPHENYL TRIAZINE (NANO)",31274-51-8,-,,10%,"Not to be used in sprays.
|
74
|
+
Only nanomaterials having the folloing characteristics are allowed:
|
75
|
+
- Median primary particle size >80 nm;
|
76
|
+
- Purity ≥ 98%;
|
77
|
+
- Uncoated
|
78
78
|
",,"(EU) 2014/866",,,"1,3,5-Triazine, 2,4,6-tris(1,1'-biphenyl)-4-yl-",,,10/10/2016
|
79
|
-
30a,"Zinc oxide (nano)","ZINC OXIDE (NANO)",1314-13-2,215-222-5,,"25%
|
80
|
-
|
81
|
-
- In case of combined use of zinc oxide and zinc oxide (nano), the sum shall not exceed the limit of 25%",,"Not to be used in applications that may lead to exposure of the end-user's lungs by inhalation.
|
82
|
-
Only nanomaterials having the following characteristics are allowed:
|
83
|
-
— purity ≥ 96 %, with wurtzite crystalline structure and physical appearance as clusters that are rod-like, star-like and/or isometric shapes, with impurities consisting only of carbon dioxide and water, whilst any other impurities are less than 1 % in total,
|
84
|
-
— median diameter of the particle number size distribution D50 (50 % of the number below this diameter) > 30 nm and D1 (1 % below this size) > 20 nm,
|
85
|
-
— water solubility < 50 mg/L
|
79
|
+
30a,"Zinc oxide (nano)","ZINC OXIDE (NANO)",1314-13-2,215-222-5,,"25%
|
80
|
+
|
81
|
+
- In case of combined use of zinc oxide and zinc oxide (nano), the sum shall not exceed the limit of 25%",,"Not to be used in applications that may lead to exposure of the end-user's lungs by inhalation.
|
82
|
+
Only nanomaterials having the following characteristics are allowed:
|
83
|
+
— purity ≥ 96 %, with wurtzite crystalline structure and physical appearance as clusters that are rod-like, star-like and/or isometric shapes, with impurities consisting only of carbon dioxide and water, whilst any other impurities are less than 1 % in total,
|
84
|
+
— median diameter of the particle number size distribution D50 (50 % of the number below this diameter) > 30 nm and D1 (1 % below this size) > 20 nm,
|
85
|
+
— water solubility < 50 mg/L
|
86
86
|
—uncoated, or coated with triethoxycaprylylsilane, dimethicone, dimethoxydiphenylsilanetriethoxycaprylylsilane cross- polymer, or octyl triethoxy silane. ","(EU) 2016/621",,"Opinion concerning Zinc oxide,Statement on Zinc Oxide used in Sunscreens,Opinion on Safety of Nanomaterials in Cosmetic Products,Clarification on Opinion SCCNFP/0932/05 on Zinc Oxide,Addendum to the Opinion SCCS/1489/12 on Zinc oxide (nano form)","Zinc oxide (nano)",,,01/03/2019
|
87
|
-
30,"Zinc oxide","ZINC OXIDE",1314-13-2,215-222-5," ","- 25%
|
88
|
-
|
89
|
-
- In case of combined use of zinc oxide and zinc oxide (nano), the sum shall not exceed the limit of 25%",,"Not to be used in applications that may lead to exposure of the end-user's lungs by inhalation.
|
87
|
+
30,"Zinc oxide","ZINC OXIDE",1314-13-2,215-222-5," ","- 25%
|
88
|
+
|
89
|
+
- In case of combined use of zinc oxide and zinc oxide (nano), the sum shall not exceed the limit of 25%",,"Not to be used in applications that may lead to exposure of the end-user's lungs by inhalation.
|
90
90
|
","(EU) 2016/621",,"Opinion concerning Zinc oxide,Statement on Zinc Oxide used in Sunscreens,Opinion on Safety of Nanomaterials in Cosmetic Products,Clarification on Opinion SCCNFP/0932/05 on Zinc Oxide,Addendum to the Opinion SCCS/1489/12 on Zinc oxide (nano form)",,"ZINC OXIDE",,13/09/2016
|
91
91
|
31,"3,3′-(1,4-Phenylene)bis(5,6-diphenyl-1,2,4-triazine)","PHENYLENE BIS-DIPHENYLTRIAZINE",55514-22-2;,700-823-1;,,5%,"Not to be used in applications that may lead to exposure of the end user's lungs by inhalation.",,"(EU) 2019/680",,"OPINION ON the safety of cosmetic ingredients Phenylene Bis-Diphenyltriazine (CAS No 55514-22-2) - S86 - Submission II,OPINION ON UV filter S86 Phenylene bis-diphenyltriazine","3,3′-(1,4-Phenylene)bis(5,6-diphenyl-1,2,4-triazine) ",,,22/09/2021
|
92
|
-
32,"2-ethoxyethyl (2Z)-2-cyano-2-[3-(3-methoxypropylamino) cyclohex-2-en-1-ylidene]acetate","Methoxypropylamino Cyclohexenylidene Ethoxyethylcyanoacetate",1419401-88-9,700-860-3,,3%,"- Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation
|
93
|
-
|
94
|
-
- Do not use with nitrosating agents
|
95
|
-
|
96
|
-
- Maximum nitrosamine content: 50 μg/kg
|
97
|
-
|
92
|
+
32,"2-ethoxyethyl (2Z)-2-cyano-2-[3-(3-methoxypropylamino) cyclohex-2-en-1-ylidene]acetate","Methoxypropylamino Cyclohexenylidene Ethoxyethylcyanoacetate",1419401-88-9,700-860-3,,3%,"- Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation
|
93
|
+
|
94
|
+
- Do not use with nitrosating agents
|
95
|
+
|
96
|
+
- Maximum nitrosamine content: 50 μg/kg
|
97
|
+
|
98
98
|
- Keep in nitrite-free containers",,"(EU) 2020/1684",,"SCCS OPINION ON Methoxypropylamino Cyclohexenylidene Ethoxyethylcyanoacetate (S87) - Submission II -,OPINION ON Methoxypropylamino Cyclohexenylidene Ethoxyethylcyanoacetate (S87) - Submission I","2-ethoxyethyl (2Z)-2-cyano-2-[3-(3-methoxypropylamino) cyclohex-2-en-1-ylidene]acetate","METHOXYPROPYLAMINO CYCLOHEXENYLIDENE ETHOXYETHYLCYANOACETATE",,24/11/2020
|
99
|
-
33,"1,1'-(1,4-piperazinediyl)bis[1-[2-[4-(diethylamino)-2-hydroxybenzoyl]phenyl]-methanone","BIS-(DIETHYLAMINOHYDROXYBENZOYL BENZOYL) PIPERAZINE",919803-06-8,485-100-6,,"10 %
|
100
|
-
|
99
|
+
33,"1,1'-(1,4-piperazinediyl)bis[1-[2-[4-(diethylamino)-2-hydroxybenzoyl]phenyl]-methanone","BIS-(DIETHYLAMINOHYDROXYBENZOYL BENZOYL) PIPERAZINE",919803-06-8,485-100-6,,"10 %
|
100
|
+
|
101
101
|
(In case of combined use of Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine and Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (nano), the sum shall not exceed 10 %).",,,"(EU) 2022/2195 ",,"OPINIONON2-(4-(2-(4-Diethylamino-2-hydroxy-benzoyl)-benzoyl)-piperazine-1-carbonyl)-phenyl)-(4-diethylamino-2-hydroxyphenyl)-methanone(HAA299) as UV filter in sunscreen products,HAA299 (nano)","1,1'-(1,4-piperazinediyl)bis[1-[2-[4-(diethylamino)-2-hydroxybenzoyl]phenyl]-methanone","Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine",,27/11/2022
|
102
|
-
34,"1,1'-(1,4-piperazinediyl)bis[1-[2-[4-(diethylamino)-2-hydroxybenzoyl]phenyl]-methanone","BIS-(DIETHYLAMINOHYDROXYBENZOYL BENZOYL) PIPERAZINE (NANO)",919803-06-8,485-100-6,,"10 %
|
103
|
-
(In case of combined use of Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine and Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (nano), the sum shall not exceed 10 %).","Only nanomaterials having the following characteristics are allowed:
|
104
|
-
— Purity ≥ 97 %
|
105
|
-
—Median particle size D50 (50 % of the number below this diameter): ≥ 50 nm of number size distribution.
|
106
|
-
Not to be used in applications that may lead to exposure of the end user’s lungs by inhalation.
|
107
|
-
|
102
|
+
34,"1,1'-(1,4-piperazinediyl)bis[1-[2-[4-(diethylamino)-2-hydroxybenzoyl]phenyl]-methanone","BIS-(DIETHYLAMINOHYDROXYBENZOYL BENZOYL) PIPERAZINE (NANO)",919803-06-8,485-100-6,,"10 %
|
103
|
+
(In case of combined use of Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine and Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine (nano), the sum shall not exceed 10 %).","Only nanomaterials having the following characteristics are allowed:
|
104
|
+
— Purity ≥ 97 %
|
105
|
+
—Median particle size D50 (50 % of the number below this diameter): ≥ 50 nm of number size distribution.
|
106
|
+
Not to be used in applications that may lead to exposure of the end user’s lungs by inhalation.
|
107
|
+
|
108
108
|
",,"(EU) 2022/2195 ",,"OPINIONON2-(4-(2-(4-Diethylamino-2-hydroxy-benzoyl)-benzoyl)-piperazine-1-carbonyl)-phenyl)-(4-diethylamino-2-hydroxyphenyl)-methanone(HAA299) as UV filter in sunscreen products,HAA299 (nano)","1,1'-(1,4-piperazinediyl)bis[1-[2-[4-(diethylamino)-2-hydroxybenzoyl]phenyl]-methanone","Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine",,27/11/2022
|